GYPA

glycophorin A (MNS blood group), the group of Blood group antigens|CD molecules

Basic information

Region (hg38): 4:144109303-144140751

Previous symbols: [ "MNS" ]

Links

ENSG00000170180NCBI:2993OMIM:617922HGNC:4702Uniprot:P02724AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Blood group, MN locus; Blood group, ErikBGHematologicVariants associated with a blood group may be important in specific situations (eg, related to transfusion)Hematologic275842; 7040988; 7052193; 8245024

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GYPA gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GYPA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
8
clinvar
3
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 8 3 0

Variants in GYPA

This is a list of pathogenic ClinVar variants found in the GYPA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-144114692-G-T not specified Uncertain significance (Nov 08, 2022)2322982
4-144114760-G-A not specified Uncertain significance (Jan 23, 2024)3103371
4-144114761-G-A not specified Likely benign (Feb 23, 2023)2488847
4-144116864-C-A not specified Uncertain significance (Jun 21, 2023)2604775
4-144116868-G-T not specified Uncertain significance (Aug 22, 2023)2621490
4-144116874-C-T not specified Uncertain significance (Mar 02, 2023)3103370
4-144116906-C-T not specified Uncertain significance (Mar 19, 2024)3283203
4-144116930-A-C not specified Uncertain significance (Apr 19, 2024)3283204
4-144118734-G-A not specified Likely benign (Mar 17, 2023)2526468
4-144119686-C-T BLOOD GROUP ERIK Pathogenic (Dec 05, 1993)17714
4-144119713-T-C not specified Uncertain significance (Aug 17, 2022)2307984
4-144119749-G-T not specified Uncertain significance (Jan 07, 2022)2270806
4-144120546-A-G not specified Likely benign (Nov 22, 2023)3103372
4-144120558-G-T not specified Uncertain significance (Oct 20, 2021)2380498

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GYPAprotein_codingprotein_codingENST00000360771 731448
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001080.842125659041256630.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5509480.21.170.00000418928
Missense in Polyphen2825.8341.0839325
Synonymous-0.02712827.81.010.00000153297
Loss of Function1.22610.20.5885.16e-7124

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006160.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002710.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Glycophorin A is the major intrinsic membrane protein of the erythrocyte. The N-terminal glycosylated segment, which lies outside the erythrocyte membrane, has MN blood group receptors. Appears to be important for the function of SLC4A1 and is required for high activity of SLC4A1. May be involved in translocation of SLC4A1 to the plasma membrane. Is a receptor for influenza virus. Is a receptor for Plasmodium falciparum erythrocyte-binding antigen 175 (EBA-175); binding of EBA-175 is dependent on sialic acid residues of the O-linked glycans. Appears to be a receptor for Hepatitis A virus (HAV). {ECO:0000269|PubMed:10926825, ECO:0000269|PubMed:12813056, ECO:0000269|PubMed:14604989, ECO:0000269|PubMed:15331714, ECO:0000269|PubMed:19438409, ECO:0000269|PubMed:8009226}.;
Pathway
Malaria - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Hematopoietic Stem Cell Differentiation;Cell surface interactions at the vascular wall;Hemostasis (Consensus)

Intolerance Scores

loftool
0.769
rvis_EVS
0.39
rvis_percentile_EVS
76.05

Haploinsufficiency Scores

pHI
0.0726
hipred
N
hipred_score
0.146
ghis
0.408

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gypa
Phenotype
hematopoietic system phenotype;

Gene ontology

Biological process
viral entry into host cell;leukocyte migration
Cellular component
plasma membrane;membrane;integral component of membrane
Molecular function
virus receptor activity;protein binding;identical protein binding